Fulltext

Assessment of varicella vaccine effectiveness in Germany: a time-series approach

HÖHLE, M. ; SIEDLER, A. ; BADER, H.-M ; LUDWIG, M. ; HEININGER, U. ; VON KRIES, R.

In: Epidemiology and Infection, 2011, vol. 139, no. 11, p. 1710-1719

Aggiungi alla tua lista
    Titre
    • Assessment of varicella vaccine effectiveness in Germany: a time-series approach
    Auteur
    • HÖHLE, M.. Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
    • SIEDLER, A.. Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
    • BADER, H.-M. Working Vaccination Committee, Ministry for Health, Schleswig-Holstein, Germany
    • LUDWIG, M.. Kassenärztliche Vereinigung Schleswig-Holstein, Germany
    • HEININGER, U.. University Children's Hospital Basel, Basel, Switzerland
    • VON KRIES, R.. Institute of Social Paediatrics and Adolescent Medicine, Ludwig-Maximilians-University München, Munich, Germany
    Type de document
    • Postprint
    Langue
    • Inglese
    Publié dans
    • Epidemiology and Infection, 2011, vol. 139, no. 11, p. 1710-1719. Cambridge University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:294213
    Summary
    A multivariate time-series regression model was developed in order to describe the 2005-2008 age-specific time-course of varicella sentinel surveillance data following the introduction of a varicella childhood vaccination programme in Germany. This ecological approach allows the assessment of vaccine effectiveness under field conditions by relating vaccine coverage in cohorts of 24-month-old children to the mean number of cases per reporting unit in the sentinel network. For the 1-2 years age group, which is directly affected by the vaccination programme, a one-dose vaccine effectiveness of 83·2% (95% CI 80·2-85·7) was estimated which corresponds to previous approaches assessing varicella vaccine effectiveness in the field in the USA